EGFR and non-small cell lung carcinoma: Another study compared the results of a hotspot EGFR T790M assay performed on matched tissue samples and plasma-derived ctDNA in 40 NSCLC patients with EGFR-mutant lung tumors who were progressing on EGFR TKI therapy.